Okla. Stat. tit. 63, § 63-2-204

The controlled substances listed in this section are included in

Schedule I and include any material, compound, mixture or

preparation that contains any quantity of the following

hallucinogenic substances, their salts, isomers and salts of

isomers, unless specifically excepted, when the existence of these

salts, isomers and salts of isomers is possible within the specific

chemical designation.

A. Any of the following opiates including their isomers,

esters, ethers, salts, and salts of isomers, esters, and ethers,

unless specifically excepted, when the existence of these isomers,

esters, ethers, and salts is possible within the specific chemical

designation:

1. Acetylmethadol;

2. Allylprodine;

3. Alphacetylmethadol;

4. Alphameprodine;

5. Alphamethadol;

6. Benzethidine;

7. Betacetylmethadol;

8. Betameprodine;

9. Betamethadol;

10. Betaprodine;

11. Clonitazene;

12. Dextromoramide;

13. Dextrorphan (except its methyl ether);

14. Diampromide;

15. Diethylthiambutene;

16. Dimenoxadol;

17. Dimepheptanol;

Oklahoma Statutes - Title 63. Public Health and Safety Page 906

18. Dimethylthiambutene;

19. Dioxaphetyl butyrate;

20. Dipipanone;

21. Ethylmethylthiambutene;

22. Etonitazene;

23. Etoxeridine;

24. Furethidine;

25. Hydroxypethidine;

26. Isotonitazene;

27. Ketobemidone;

28. Levomoramide;

29. Levophenacylmorphan;

30. Metonitazene;

31. Morpheridine;

32. N-desethyl isotonitazene;

33. N-pyrrolidino protonitazene;

34. Noracymethadol;

35. Norlevorphanol;

36. Normethadone;

37. Norpipanone;

38. Phenadoxone;

39. Phenampromide;

40. Phenomorphan;

41. Phenoperidine;

42. Piritramide;

43. Proheptazine;

44. Properidine;

45. Protonitazene;

46. Racemoramide; or

47. Trimeperidine.

B. Any of the following opium derivatives, their salts,

isomers, and salts of isomers, unless specifically excepted, when

the existence of these salts, isomers, and salts of isomers is

possible within the specific chemical designation:

1. Acetorphine;

2. Acetyldihydrocodeine;

3. Benzylmorphine;

4. Codeine methylbromide;

5. Codeine-N-Oxide;

6. Cyprenorphine;

7. Desomorphine;

8. Dihydromorphine;

9. Etorphine;

10. Heroin;

11. Hydromorphinol;

12. Methyldesorphine;

13. Methylhydromorphine;

Oklahoma Statutes - Title 63. Public Health and Safety Page 907

14. Morphine methylbromide;

15. Morphine methylsulfonate;

16. Morphine-N-Oxide;

17. Myrophine;

18. Nicocodeine;

19. Nicomorphine;

20. Normorphine;

21. Phoclodine;

22. Thebacon;

23. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-acetamide

(Acetyl fentanyl);

24. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-butenamide

(Crotonyl fentanyl);

25. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-2-

furancarboxamide (Furanyl fentanyl);

26. N-phenyl-1-(2-phenylethyl)-4-piperidinamine (4-ANPP);

27. N-(1-phenethylpiperidin-4-yl)-N-

phenylcyclopropanecarboxamide (Cyclopropyl fentanyl); or

28. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide

(Butyrl fentanyl).

C. Any material, compound, mixture, or preparation which

contains any quantity of the following hallucinogenic substances,

their salts, isomers, and salts of isomers, unless specifically

excepted, when the existence of these salts, isomers, and salts of

isomers is possible within the specific chemical designation:

1. Methcathinone;

2. 3, 4-methylenedioxy amphetamine;

3. 3, 4-methylenedioxy methamphetamine;

4. 5-methoxy-3, 4-methylenedioxy amphetamine;

5. 3, 4, 5-trimethoxy amphetamine;

6. Bufotenine;

7. Diethyltryptamine;

8. Dimethyltryptamine;

9. 4-methyl-2, 5-dimethoxyamphetamine;

10. Ibogaine;

11. Lysergic acid diethylamide;

12. Marijuana;

13. Mescaline;

14. N-benzylpiperazine;

15. N-ethyl-3-piperidyl benzilate;

16. N-methyl-3-piperidyl benzilate;

17. Psilocybin;

18. Psilocyn;

19. 2, 5 dimethoxyamphetamine;

20. 4 Bromo-2, 5-dimethoxyamphetamine;

21. 4 methoxyamphetamine;

22. Cyclohexamine;

Oklahoma Statutes - Title 63. Public Health and Safety Page 908
amine;

10. Ibogaine;

11. Lysergic acid diethylamide;

12. Marijuana;

13. Mescaline;

14. N-benzylpiperazine;

15. N-ethyl-3-piperidyl benzilate;

16. N-methyl-3-piperidyl benzilate;

17. Psilocybin;

18. Psilocyn;

19. 2, 5 dimethoxyamphetamine;

20. 4 Bromo-2, 5-dimethoxyamphetamine;

21. 4 methoxyamphetamine;

22. Cyclohexamine;

Oklahoma Statutes - Title 63. Public Health and Safety Page 908

23. Salvia Divinorum;

24. Salvinorin A;

25. Thiophene Analog of Phencyclidine. Also known as: 1-(1-(2-

thienyl) cyclohexyl) piperidine; 2-Thienyl Analog of Phencyclidine;

TPCP, TCP;

26. Phencyclidine (PCP);

27. Pyrrolidine Analog for Phencyclidine. Also known as 1-(1-

Phenylcyclohexyl) - Pyrrolidine, PCPy, PHP;

28. 1-(3-trifluoromethylphenyl) piperazine;

29. Flunitrazepam;

30. B-hydroxy-amphetamine;

31. B-ketoamphetamine;

32. 2,5-dimethoxy-4-nitroamphetamine;

33. 2,5-dimethoxy-4-bromophenethylamine;

34. 2,5-dimethoxy-4-chlorophenethylamine;

35. 2,5-dimethoxy-4-iodoamphetamine;

36. 2,5-dimethoxy-4-iodophenethylamine;

37. 2,5-dimethoxy-4-methylphenethylamine;

38. 2,5-dimethoxy-4-ethylphenethylamine;

39. 2,5-dimethoxy-4-fluorophenethylamine;

40. 2,5-dimethoxy-4-nitrophenethylamine;

41. 2,5-dimethoxy-4-ethylthio-phenethylamine;

42. 2,5-dimethoxy-4-isopropylthio-phenethylamine;

43. 2,5-dimethoxy-4-propylthio-phenethylamine;

44. 2,5-dimethoxy-4-cyclopropylmethylthio-phenethylamine;

45. 2,5-dimethoxy-4-tert-butylthio-phenethylamine;

46. 2,5-dimethoxy-4-(2-fluoroethylthio)-phenethylamine;

47. 5-methoxy-N, N-dimethyltryptamine;

48. N-methyltryptamine;

49. A-ethyltryptamine;

50. A-methyltryptamine;

51. N, N-diethyltryptamine;

52. N, N-diisopropyltryptamine;

53. N, N-dipropyltryptamine;

54. 5-methoxy-a-methyltryptamine;

55. 4-hydroxy-N, N-diethyltryptamine;

56. 4-hydroxy-N, N-diisopropyltryptamine;

57. 5-methoxy-N, N-diisopropyltryptamine;

58. 4-hydroxy-N-isopropyl-N-methyltryptamine;

59. 3,4-Methylenedioxymethcathinone (Methylone);

60. 3,4-Methylenedioxypyrovalerone (MDPV);

61. 3-Methylmethcathinone (Metaphedrone);

62. 4-Methylmethcathinone (Mephedrone);

63. 4-methoxymethcathinone;

64. 4-Fluoromethcathinone;

65. 3-Fluoromethcathinone;

66. 1-(8-bromobenzo 1,2-b;4,5-b’ difuran-4-yl)-2-aminopropane;

Oklahoma Statutes - Title 63. Public Health and Safety Page 909

67. 2,5-Dimethoxy-4-chloroamphetamine;

68. 4-Methylethcathinone;

69. Pyrovalerone;

70. N,N-diallyl-5-methoxytryptamine;

71. 3,4-Methylenedioxy-N-ethylcathinone (Ethylone);

72. B-keto-N-Methylbenzodioxolylbutanamine (Butylone);

73. B-keto-Methylbenzodioxolylpentanamine (Pentylone);

74. Alpha-Pyrrolidinopentiophenone;

75. 4-Fluoroamphetamine;

76. Pentedrone;

77. 4’-Methyl-a-pyrrolidinohexaphenone;

78. 2,5-dimethoxy-4-(n)-propylphenethylamine;

79. 2,5-dimethoxyphenethylamine;

80. 1,4-Dibenzylpiperazine;

81. N,N-Dimethylamphetamine;

82. 4-Fluoromethamphetamine;

83. 4-Chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine

(25C-NBOMe);

84. 4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine

(25I-NBOMe);

85. 4-Bromo-2,5-dimethoxy-N-(2-methoxybenzy)phenethylamine

(25B-NBOMe);

86. 1-(4-Fluorophenyl)piperazine;

87. Methoxetamine;

88. 3,4-dichloro-N[2-dimethylamino)cyclohexyl]-N-

methylbenzamide;

89. N-ethyl hexadrone;

90. Isopropyl-U-47700;

91. Para-fluorobutyrl fentanyl;

92. Para-fluorofentanyl (pFF);

93. Fluoro isobutryrl fentanyl;

94. 3-Hydroxy Phencyclidine (PCP);

95. 3-methoxy Phencyclidine (PCP);

96. Flualprazolam; or

97. Flubromazolam.

D. Unless specifically excepted or unless listed in a different

schedule, any material, compound, mixture, or preparation which

contains any quantity of the following substances having stimulant

or depressant effect on the central nervous system:

1. Fenethylline;

2. Mecloqualone;

3. N-ethylamphetamine;

4. Methaqualone;

5. Gamma-Hydroxybutyric Acid, also known as GHB, gamma-

hydroxybutyrate, 4-hydroxybutyrate, 4-hydroxybutanoic acid, sodium
a different

schedule, any material, compound, mixture, or preparation which

contains any quantity of the following substances having stimulant

or depressant effect on the central nervous system:

1. Fenethylline;

2. Mecloqualone;

3. N-ethylamphetamine;

4. Methaqualone;

5. Gamma-Hydroxybutyric Acid, also known as GHB, gamma-

hydroxybutyrate, 4-hydroxybutyrate, 4-hydroxybutanoic acid, sodium

oxybate, and sodium oxybutyrate;

Oklahoma Statutes - Title 63. Public Health and Safety Page 910

6. Gamma-Butyrolactone (GBL) as packaged, marketed,

manufactured or promoted for human consumption, with the exception

of legitimate food additive and manufacturing purposes;

7. Gamma Hydroxyvalerate (GHV) as packaged, marketed, or

manufactured for human consumption, with the exception of legitimate

food additive and manufacturing purposes;

8. Gamma Valerolactone (GVL) as packaged, marketed, or

manufactured for human consumption, with the exception of legitimate

food additive and manufacturing purposes;

9. 1,4 Butanediol (1,4 BD or BDO) as packaged, marketed,

manufactured, or promoted for human consumption with the exception

of legitimate manufacturing purposes; or

10. N-ethylpentylone.

E. 1. The following industrial uses of Gamma-Butyrolactone,

Gamma Hydroxyvalerate, Gamma Valerolactone, or 1,4 Butanediol are

excluded from all schedules of controlled substances under this

title:

a. pesticides,

b. photochemical etching,

c. electrolytes of small batteries or capacitors,

d. viscosity modifiers in polyurethane,

e. surface etching of metal coated plastics,

f. organic paint disbursements for water soluble inks,

g. pH regulators in the dyeing of wool and polyamide

fibers,

h. foundry chemistry as a catalyst during curing,

i. curing agents in many coating systems based on

urethanes and amides,

j. additives and flavoring agents in food, confectionary,

and beverage products,

k. synthetic fiber and clothing production,

l. tetrahydrofuran production,

m. gamma butyrolactone production,

n. polybutylene terephthalate resin production,

o. polyester raw materials for polyurethane elastomers

and foams,

p. coating resin raw material, and

q. as an intermediate in the manufacture of other

chemicals and pharmaceuticals.

2. At the request of any person, the Director of the Oklahoma

State Bureau of Narcotics and Dangerous Drugs Control may exempt any

other product containing Gamma-Butyrolactone, Gamma Hydroxyvalerate,

Gamma Valerolactone, or 1,4 Butanediol from being included as a

Schedule I controlled substance if such product is labeled,

marketed, manufactured and distributed for legitimate industrial use

in a manner that reduces or eliminates the likelihood of abuse.

Oklahoma Statutes - Title 63. Public Health and Safety Page 911

3. In making a determination regarding an industrial product,

the Director, after notice and hearing, shall consider the

following:

a. the history and current pattern of abuse,

b. the name and labeling of the product,

c. the intended manner of distribution, advertising and

promotion of the product, and

d. other factors as may be relevant to and consistent

with the public health and safety.

4. The hearing shall be held in accordance with the procedures

of the Administrative Procedures Act.

F. Any material, compound, mixture, or preparation, whether

produced directly or indirectly from a substance of vegetable origin

or independently by means of chemical synthesis, or by a combination

of extraction and chemical synthesis, that contains any quantity of

the following substances, or that contains any of their salts,

isomers, and salts of isomers when the existence of these salts,

isomers, and salts of isomers is possible within the specific

chemical designation:

1. JWH-004;

2. JWH-007;

3. JWH-009;

4. JWH-015;

5. JWH-016;

6. JWH-018;

7. JWH-019;

8. JWH-020;

9. JWH-030;

10. JWH-046;

11. JWH-047;

12. JWH-048;

13. JWH-049;

14. JWH-050;

15. JWH-070;
ubstances, or that contains any of their salts,

isomers, and salts of isomers when the existence of these salts,

isomers, and salts of isomers is possible within the specific

chemical designation:

1. JWH-004;

2. JWH-007;

3. JWH-009;

4. JWH-015;

5. JWH-016;

6. JWH-018;

7. JWH-019;

8. JWH-020;

9. JWH-030;

10. JWH-046;

11. JWH-047;

12. JWH-048;

13. JWH-049;

14. JWH-050;

15. JWH-070;

16. JWH-071;

17. JWH-072;

18. JWH-073;

19. JWH-076;

20. JWH-079;

21. JWH-080;

22. JWH-081;

23. JWH-082;

24. JWH-094;

25. JWH-096;

26. JWH-098;

27. JWH-116;

28. JWH-120;

Oklahoma Statutes - Title 63. Public Health and Safety Page 912

29. JWH-122;

30. JWH-145;

31. JWH-146;

32. JWH-147;

33. JWH-148;

34. JWH-149;

35. JWH-150;

36. JWH-156;

37. JWH-167;

38. JWH-175;

39. JWH-180;

40. JWH-181;

41. JWH-182;

42. JWH-184;

43. JWH-185;

44. JWH-189;

45. JWH-192;

46. JWH-193;

47. JWH-194;

48. JWH-195;

49. JWH-196;

50. JWH-197;

51. JWH-198;

52. JWH-199;

53. JWH-200;

54. JWH-201;

55. JWH-202;

56. JWH-203;

57. JWH-204;

58. JWH-205;

59. JWH-206;

60. JWH-207;

61. JWH-208;

62. JWH-209;

63. JWH-210;

64. JWH-211;

65. JWH-212;

66. JWH-213;

67. JWH-234;

68. JWH-235;

69. JWH-236;

70. JWH-237;

71. JWH-239;

72. JWH-240;

73. JWH-241;

74. JWH-242;

75. JWH-243;

Oklahoma Statutes - Title 63. Public Health and Safety Page 913

76. JWH-244;

77. JWH-245;

78. JWH-246;

79. JWH-248;

80. JWH-249;

81. JWH-250;

82. JWH-251;

83. JWH-252;

84. JWH-253;

85. JWH-262;

86. JWH-292;

87. JWH-293;

88. JWH-302;

89. JWH-303;

90. JWH-304;

91. JWH-305;

92. JWH-306;

93. JWH-307;

94. JWH-308;

95. JWH-311;

96. JWH-312;

97. JWH-313;

98. JWH-314;

99. JWH-315;

100. JWH-316;

101. JWH-346;

102. JWH-348;

103. JWH-363;

104. JWH-364;

105. JWH-365;

106. JWH-367;

107. JWH-368;

108. JWH-369;

109. JWH-370;

110. JWH-371;

111. JWH-373;

112. JWH-386;

113. JWH-387;

114. JWH-392;

115. JWH-394;

116. JWH-395;

117. JWH-397;

118. JWH-398;

119. JWH-399;

120. JWH-400;

121. JWH-412;

122. JWH-413;

Oklahoma Statutes - Title 63. Public Health and Safety Page 914

123. JWH-414;

124. JWH-415;

125. CP-55, 940;

126. CP-47, 497;

127. HU-210;

128. HU-211;

129. WIN-55, 212-2;

130. AM-2201;

131. AM-2233;

132. JWH-018 adamantyl-carboxamide;

133. AKB48;

134. JWH-122 N-(4-pentenyl)analog;

135. MAM2201;

136. URB597;

137. URB602;

138. URB754;

139. UR144;

140. XLR11;

141. A-796,260;

142. STS-135;

143. AB-FUBINACA;

144. AB-PINACA;

145. PB-22;

146. AKB48 N-5-Fluorpentyl;

147. AM1248;

148. FUB-PB-22;

149. ADB-FUBINACA;

150. BB-22;

151. 5-Fluoro PB-22; or

152. 5-Fluoro AKB-48.

G. In addition to those substances listed in subsection F of

this section, unless specifically excepted or unless listed in

another schedule, any material, compound, mixture, or preparation

which contains any quantity of a synthetic cannabinoid found to be

in any of the following chemical groups:

1. Naphthoylindoles: any compound containing a 3-(1-

naphthoyl)indole structure with or without substitution at the

nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl,

alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-

(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-

2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,

(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or

halophenyl group, whether or not further substituted on the indole

ring to any extent, and whether or not substituted on the naphthyl

ring to any extent. Naphthoylindoles include, but are not limited

to:

Oklahoma Statutes - Title 63. Public Health and Safety Page 915

a. 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-

200),

b. 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201),

c. 1-pentyl-3-(1-naphthoyl)indole (JWH-018),

d. 1-butyl-3-(1-naphthoyl)indole (JWH-073),

e. 1-pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081),

f. 1-propyl-2-methyl-3-(1-naphthoyl)indole (JWH-015),
limited

to:

Oklahoma Statutes - Title 63. Public Health and Safety Page 915

a. 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-

200),

b. 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201),

c. 1-pentyl-3-(1-naphthoyl)indole (JWH-018),

d. 1-butyl-3-(1-naphthoyl)indole (JWH-073),

e. 1-pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081),

f. 1-propyl-2-methyl-3-(1-naphthoyl)indole (JWH-015),

g. 1-hexyl-3-(1-naphthoyl)indole (JWH-019),

h. 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122),

i. 1-pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH-210),

j. 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398),

k. 1-pentyl-2-methyl-3-(1-naphthoyl)indole (JWH-007),

l. 1-pentyl-3-(7-methoxy-1-naphthoyl)indole (JWH-164),

m. 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole

(JWH-098),

n. 1-pentyl-3-(4-fluoro-1-naphthoyl)indole (JWH-412),

o. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(1-

naphthoyl)indole (AM-1220),

p. 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole

(MAM-2201), or

q. 1-(4-cyanobutyl)-3-(1-naphthoyl)indole (AM-2232);

2. Naphthylmethylindoles: any compound containing a 1H-indol-3-

yl-(1-naphthyl)methane structure with or without substitution at the

nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl,

alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-

(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-

2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,

(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or

halophenyl group, whether or not further substituted on the indole

ring to any extent, and whether or not substituted on the naphthyl

ring to any extent. Naphthylmethylindoles include, but are not

limited to, (1-pentylindol-3-yl)(1-naphthyl)methane (JWH-175);

3. Naphthoylpyrroles: any compound containing a 3-(1-

naphthoyl)pyrrole structure with or without substitution at the

nitrogen atom of the pyrrole ring by an alkyl, haloalkyl,

cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl,

halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-

morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-

morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl,

phenyl, or halophenyl group, whether or not further substituted on

the pyrrole ring to any extent, and whether or not substituted on

the naphthyl group to any extent. Naphthoylpyrroles include, but

are not limited to:

a. 1-hexyl-2-phenyl-4-(1-naphthoyl)pyrrole (JWH-147),

b. 1-pentyl-5-(2-methylphenyl)-3-(1-naphthoyl)pyrrole

(JWH-370),

c. 1-pentyl-3-(1-naphthoyl)pyrrole (JWH-030), or

Oklahoma Statutes - Title 63. Public Health and Safety Page 916

d. 1-hexyl-5-phenyl-3-(1-naphthoyl)pyrrole (JWH-147);

4. Naphthylideneindenes: any compound containing a 1-(1-

naphthylmethylene)indene structure with or without substitution at

the 3-position of the indene ring by an alkyl, haloalkyl,

cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl,

halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-

morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-

morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl,

phenyl, or halophenyl group, whether or not further substituted on

the indene group to any extent, and whether or not substituted on

the naphthyl group to any extent. Naphthylmethylindenes include,

but are not limited to, (1-[(3-pentyl)-1H-inden-1-

ylidene)methyl]naphthalene (JWH-176);

5. Phenylacetylindoles: any compound containing a 3-

phenylacetylindole structure with or without substitution at the

nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl,

alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-

(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-

2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,

(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or

halophenyl group, whether or not further substituted on the indole
n at the

nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl,

alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-

(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-

2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,

(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or

halophenyl group, whether or not further substituted on the indole

ring to any extent, and whether or not substituted on the phenyl

ring to any extent. Phenylacetylindoles include, but are not

limited to:

a. 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250),

b. 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole

(RCS-8),

c. 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203),

d. 1-pentyl-3-(2-methylphenylacetyl)indole (JWH-251),

e. 1-pentyl-3-(4-methoxyphenylacetyl)indole (JWH-201), or

f. 1-pentyl-3-(3-methoxyphenylacetyl)indole (JWH-302);

6. Cyclohexylphenols: any compound containing a 2-(3-

hydroxycyclohexyl)phenol structure with or without substitution at

the 5-position of the phenolic ring by an alkyl, haloalkyl,

cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl,

halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-

morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-

morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl,

phenyl, or halophenyl group, and whether or not further substituted

on the cyclohexyl ring to any extent. Cyclohexylphenols include,

but are not limited to:

a. 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-

hydroxycyclohexyl]-phenol (CP-47,497),

b. 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-

phenol (cannabicyclohexanol; CP-47,497 C8 homologue),

or

Oklahoma Statutes - Title 63. Public Health and Safety Page 917

c. 5-(1,1-dimethylheptyl)-2-[(1R,2R)-5-hydroxy-2-(3-

hydroxypropyl)cyclohexyl]-phenol (CP 55, 940);

7. Benzoylindoles: any compound containing a 3-(benzoyl)indole

structure with or without substitution at the nitrogen atom of the

indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,

cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-

2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-

pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,

(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or

halophenyl group, whether or not further substituted on the indole

ring to any extent, and whether or not substituted on the phenyl

group to any extent. Benzoylindoles include, but are not limited

to:

a. 1-pentyl-3-(4-methoxybenzoyl)indole (RCS-4),

b. 1-[2-(4-morpholinyl)ethyl]-2-methyl-3-(4-

methoxybenzoyl)indole (Pravadoline or WIN 48, 098),

c. 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694),

d. 1-pentyl-3-(2-iodobenzoyl)indole (AM-679), or

e. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-

iodobenzoyl)indole (AM-2233);

8. Cyclopropoylindoles: Any compound containing a 3-

(cyclopropoyl)indole structure with substitution at the nitrogen

atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,

cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-

2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-

pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,

(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or

halophenyl group, whether or not further substituted in the indole

ring to any extent and whether or not substituted in the

cyclopropoyl ring to any extent. Cyclopropoylindoles include, but

are not limited to:

a. 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole

(UR-144),

b. 1-(5-chloropentyl)-3-(2,2,3,3-

tetramethylcyclopropoyl)indole (5Cl-UR-144), or

c. 1-(5-fluoropentyl)-3-(2,2,3,3-

tetramethylcyclopropoyl)indole (XLR11);

9. Indole Amides: Any compound containing a 1H-Indole-3-

carboxamide structure with or without substitution at the nitrogen

atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,

cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-
-(2,2,3,3-

tetramethylcyclopropoyl)indole (5Cl-UR-144), or

c. 1-(5-fluoropentyl)-3-(2,2,3,3-

tetramethylcyclopropoyl)indole (XLR11);

9. Indole Amides: Any compound containing a 1H-Indole-3-

carboxamide structure with or without substitution at the nitrogen

atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,

cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-

2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-

pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,

(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or

halophenyl group, whether or not substituted at the carboxamide

group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,

cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-

Oklahoma Statutes - Title 63. Public Health and Safety Page 918

1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-

dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not

further substituted in the indole, adamantyl, naphthyl, phenyl,

pyrrole, quninolinyl, or cycloalkyl rings to any extent. Indole

Amides include, but are not limited to:

a. N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide

(2NE1),

b. N-(1-adamantyl)-1-(5-fluoropentyl-1H-indole-3-

carboxamide (STS-135),

c. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-

indole-3-carboxamide (ADBICA),

d. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-

fluoropentyl)-1H-indole-3-carboxamide (5F-ADBICA),

e. N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide

(NNE1),

f. 1-(5-fluoropentyl)-N-(naphthalene-1-yl)-1H-indole-3-

carboxamide (5F-NNE1),

g. N-benzyl-1-pentyl-1H-indole-3-carboxamide (SDB-006),

or

h. N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide

(5F-SDB-006);

10. Indole Esters: Any compound containing a 1H-Indole-3-

carboxylate structure with or without substitution at the nitrogen

atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,

cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-

2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-

pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl,

(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or

halophenyl group, whether or not substituted at the carboxylate

group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,

cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-

1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-

dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not

further substituted in the indole, adamantyl, naphthyl, phenyl,

pyrrole, quinolinyl, or cycloalkyl rings to any extent. Indole

Esters include, but are not limited to:

a. quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-

22),

b. quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-

carboxylate (5F-PB-22),

c. quinolin-8-yl 1-(cyclohexylmethyl)-1H-indole-3-

carboxylate (BB-22),

d. naphthalen-1-yl 1-(4-fluorobenzyl)-1H-indole-3-

carboxylate (FDU-PB-22), or

e. naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-

carboxylate (NM2201);

Oklahoma Statutes - Title 63. Public Health and Safety Page 919

11. Adamantanoylindoles: Any compound containing an

adamantanyl-(1H-indol-3-yl)methanone structure with or without

substitution at the nitrogen atom of the indole ring by an alkyl,

haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,

benzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-

morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-

morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl,

phenyl, or halophenyl group, whether or not further substituted in

the indole ring to any extent and whether or not substituted in the

adamantyl ring to any extent. Adamantanoylindoles include, but are

not limited to:

a. adamantan-1-yl[1-[(1-methyl-2-piperidinyl)methyl]-1H-

indol-3-yl]methanone (AM1248), or

b. adamantan-1-yl-(1-pentyl-1H-indol-3-yl)methanone (AB-

001);
l, 1-methylazepanyl,

phenyl, or halophenyl group, whether or not further substituted in

the indole ring to any extent and whether or not substituted in the

adamantyl ring to any extent. Adamantanoylindoles include, but are

not limited to:

a. adamantan-1-yl[1-[(1-methyl-2-piperidinyl)methyl]-1H-

indol-3-yl]methanone (AM1248), or

b. adamantan-1-yl-(1-pentyl-1H-indol-3-yl)methanone (AB-

001);

12. Carbazole Ketone: Any compound containing (9H-carbazole-3-

yl) methanone structure with or without substitution at the nitrogen

atom of the carbazole ring by an alkyl, haloalkyl, cyanoalkyl,

alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-

(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-

2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl,

(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or

halophenyl group, with substitution at the carbon of the methanone

group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,

cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-

1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-

dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not

further substituted at the carbazole, adamantyl, naphthyl, phenyl,

pyrrole, quinolinyl, or cycloalkyl rings to any extent. Carbazole

Ketones include, but are not limited to, naphthalen-1-yl(9-pentyl-

9H-carbazol-3-yl)methanone (EG-018);

13. Benzimidazole Ketone: Any compound containing

(benzimidazole-2-yl) methanone structure with or without

substitution at either nitrogen atom of the benzimidazole ring by an

alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,

cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-

piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-

pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl,

(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or

halophenyl group, with substitution at the carbon of the methanone

group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,

cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-

1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-

dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not

further substituted in the benzimidazole, adamantyl, naphthyl,

phenyl, pyrrole, quinolinyl, or cycloalkyl rings to any extent.

Benzimidazole Ketones include, but are not limited to:

Oklahoma Statutes - Title 63. Public Health and Safety Page 920

a. naphthalen-1-yl(1-pentyl-1H-benzo[d]imidazol-2-

l)methanone (JWH-018 benzimidazole analog), or

b. (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-

yl)(naphthalen-1-yl)methanone (FUBIMINA); and

14. Modified by Replacement: any compound defined in this

subsection that is modified by replacement of a carbon with nitrogen

in the indole, naphthyl, indene, benzimidazole, or carbazole ring.

H. Any prescription drug approved by the federal Food and Drug

Administration under the provisions of Section 505 of the Federal

Food, Drug and Cosmetic Act, Title 21 of the United States Code,

Section 355, that is designated, rescheduled or deleted as a

controlled substance under federal law by the United States Drug

Enforcement Administration shall be excluded from Schedule I and

shall be prescribed, distributed, dispensed or used in accordance

with federal law upon the issuance of a notice, final rule or

interim final rule by the United States Drug Enforcement

Administration designating, rescheduling or deleting as a controlled

substance such a drug product under federal law, unless and until

the State Board of Pharmacy takes action pursuant to Section 2-201

of this title. If the Board of Pharmacy does not take action

pursuant to Section 2-201 of this title, the drug product shall be

deemed to be designated, rescheduled or deleted as a controlled

substance in accordance with federal law and in compliance with the

Uniform Controlled Dangerous Substances Act.